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Summary 
Background Adults with intellectual disabilities have substantial health inequalities and poor access to 
health care. We assessed whether practice nurse-delivered health checks could improve the health of 
adults with intellectual disabilities compared with standard care. 
 
Methods In this cluster-design, single-blind, randomised controlled trial, we included general practices 
in Scotland, UK. From June to December, 2011, we randomly assigned (1:1) these general practices to 
either health checks plus standard care (health-checks group), or standard care only (control group), 
and we recruited the patients from these practices. Randomisation was done with stratification by 
number of GPs per practice and number of registered patients with intellectual disabilities (<20 or 
≥20). Two research assistants were masked to allocation, and undertook the review of 9 month 
medical records and interviews. Participants and carers were not masked. The intervention was one 
health check designed especially for people with intellectual disabilities delivered by a practice nurse. 
The objective was improvement in health and health care 9 months after randomisation, and the 
primary outcome was the incidence of newly detected health needs being met by this timepoint. 
Whether needs were met was established by the investigators being masked to group allocation. The 
analysis was by intention to treat. This trial is registered with Current Controlled Trials, number 
ISRCTN43324841. 
 
Findings Between June 26 and Dec 20, 2011, we recruited 38 practices. 85 participants (from 16 
practices) were randomly assigned to intervention and 67 (from 17 practices) to standard care; five of 
the identified practices did not supply any participants. 83 intervention and 66 standard care 
participants completed the trial. More newly detected health needs were met in the intervention group 
than in the control standard care group (median 1 [range 0–8], 76.4% met [SD 36.5] vs 2 [0-11], 
72.6% met [35.4]; odds ratio [OR] 1.73 [95% CI 0.93–3.22], p=0.085), although this difference was 
not significant. Significantly more health monitoring needs were met in the intervention group than 
standard care (median 2 [0–20], 69.9% [SD 34.2] vs 2 [0–22], 56.8% [29.4], OR 2.38 [95% CI 1.31–
4.32, p=0.0053]). The probability that health checks are cost effective was between 0.6 and 0.8, 
irrespective of the cost-effectiveness threshold level. Costs per patient were –£71.48 for health checks 
and –£20.56 for standard care. The difference (–£50.92) was not significant [95% CI –434 to 362]. No 
adverse events were attributable to the intervention. 
 
Interpretation Health checks given by practice nurses to adults with intellectual disabilities produced 
health-care improvements that were more conducive to longer-term health than standard care given to 
this population. The intervention dominated standard care, being both cheaper and more effective. 
Health-check programmes might therefore be indicated for adults with intellectual disabilities. 
 
Funding Scottish Government Change Fund, NHS Greater Glasgow and Clyde Research and 
Development.   
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Introduction 
People with intellectual disabilities encounter substantial health inequalities. The standardised mortality 
ratio for people with moderate to profound intellectual disabilities is 324 in the UK.1 This population has 
very poor health and multimorbidity; eg, point prevalence of mental health disorders for this 
population globally is 41%,2 problem behaviour 23%,3 epilepsy 25%,4 sensory impairments 50%,5–8 
and gastro-oesophageal reflux disorder 50%.9 Swallowing problems, which can cause choking or 
aspiration,4 are common in this population, as are injuries, accidents, and falls.10 These health needs 
have biological, social, and environmental determinants, including poorer access to health care.4,11–15 A 
lot of health needs of this population are unmet, and present at more advanced disease stages, with 
worsened treatment outcomes. Additionally, effects of poor health care accumulate across their 
lifespan, rather than merely being late-life issues that the general population might experience, which 
could compound difficulties for the intellectually disabled population over time.  
 
The patterns of ill health, common causes of death, and health-related behaviours in adults with 
intellectual disabilities differ from the general population.4 Smoking and excess alcohol consumption 
are uncommon, but communication difficulties make these people reliant on carers noticing their 
problems and taking action.4 Background, training, motivation, and understanding of carers, and 
communication within and across care teams influence whether they notice such problems. By 
definition, people with intellectual disabilities need additional support in their daily or social functioning. 
In the UK, such support is typically provided by family carers, or by carers employed by support-
providing organisations who provide care to an individual in their own home, ranging from a few hours 
per week to 24 h support every day, depending on the individual’s needs. Attitudes and skills of health 
professionals also affect the support given, and diagnostic overshadowing (the attribution of a person’s 
symptoms and signs to their underlying intellectual disabilities, rather than their additional health 
needs) is well recognised. There is no National Health Service (NHS) equivalent of paediatric services 
for adults with intellectual disabilities, so responsibility for their care is given to primary care, within 
which—for many reasons— it is challenging to address these needs. 
 
The challenges encountered have led to calls for health checks for adults with intellectual disabilities. 
Health checks for the general population without selection for risk factors or disease are ineffective.16 A 
systematic review16 suggested that such systematic screening might not be needed because this 
screening takes place in general practice anyway, and uptake tends to be by people from high 
socioeconomic status groups who are at decreased risk. However, this systematic review16 excluded 
trials with the high-risk geriatric population. These conclusions are also unlikely to apply to adults with 
intellectual disabilities, because they are also a high-risk group, with a low use of primary care, and 
low socioeconomic status. Additionally, general health checks designed for the general population such 
as the midlife-NHS health check offered in England are not focused on the types of illnesses and 
disabling disorders that are most prevalent for adults with intellectual disabilities. However, health-
check evidence related to adults with intellectual disabilities is scarce, with little information from 
randomised trials, or about health-check costs, acceptability, barriers to uptake, implementation of 
actions resulting from health checks, or their effect on future health and wellbeing.17 
 
A dedicated training route exists to become a registered intellectual disabilities nurse in the UK. This 
route is a 3 year course that does not require a previous nursing qualification, and is different from the 
role of nurse practitioners or liaison nurses. A non-randomised intervention study18 in Scotland 
investigated 50 adults with intellectual disabilities who were health checked by intellectual disabilities 
nurses, matched for sex, age, and ability, and 50 who received treatment as usual (standard care). 
After 1 year, the intervention group had substantially more health, health monitoring, and health-
promotion needs met, and the intervention was inexpensive.18,19 However, the health check took 4 h, 
and outcomes might have been improved with health checks done by GPs or practice nurses, since the 
study identified predominantly general health needs. An Australian trial randomly assigned 453 adults 
receiving paid support from one provider, into 34 clusters.20 Improvements in health promotions (eg, 
sensory impairment testing, immunisations, and cervical screening) were noted in the GP-delivered 
health-check intervention group 1 year later, but no significant difference in newly detected diseases 
was noted (p=0.07).20 This intervention was also inexpensive.21 Results from another Australian cluster 
trial that randomly assigned 272 participants to combined health advocacy with the GP-delivered 
health assessment, or standard care, showed no additional benefits for the intervention.22 The extent 
of health actions from these checks was greater than that recorded in GP records.23 However, the 
health-care system in Australia differs from the that in the UK (eg, patients do not register with a GP), 
and many organisations provide paid support, so results might not be generalisable. We have not 
3 
 
identified any trials of health checks for adults with intellectual disabilities delivered by practice nurses 
rather than GPs. Within the UK, the number of practice nurses delivering specific types of management 
for long-term disorders—eg, checks for people with diabetes, physical health of people with psychosis—
has increased, which suggests that this type of management might provide a model to address the 
health inequalities of adults with intellectual disabilities. 
 
We aimed to identify the clinical and cost-effectiveness of health checks designed for adults with 
intellectual disabilities and delivered by practice nurses, compared with standard care for these 
patients. 
 
 
Methods 
Trial design and participants 
We used a stratified, cluster, randomised, controlled design. The objective was aimed at the individual 
level, but we used a cluster design to avoid contamination of intervention effects at general practice 
level. We recruited GP practices, then enrolled up to ten patients per practice. We invited 102 practices 
and expected to recruit about 60 practices, but achieved the participant numbers needed after 
recruiting 38 practices between June 21 and Dec 20, 2011. 
 
We obtained baseline data, then randomly assigned practices to either standard care plus the 
intervention (health checks delivered by practice nurses), or standard care only. Follow-up was 9 
months after randomisation. Participants received £50 for their time. Practices received £100 per 
health check. No changes were made to the trial design during implementation. Unlike England, health 
checks for adults with intellectual disabilities are not part of the Scottish GP contract and so are not 
routinely offered; hence the advantage of doing the study in Scotland. Standard care provided by 
general practice for people with intellectual disabilities in Scotland is the same as that provided for the 
general population. 
 
We included adults aged 18 years or more with intellectual disabilities who were registered at a 
participating practice. Exclusion criteria were no valid consent, terminal illness, or their GP regarding 
the invitation as inappropriate. 
 
MREC–Scotland A and NHS Greater Glasgow and Clyde Research and Development approved the study 
(10/MRE00/79). Participant consent was in agreement with Scottish law (the Adults with Incapacity 
[Scotland] Act, 2000), where participants with intellectual disabilities provided written consent if they 
had the decision-making capacity to do so; otherwise, their welfare guardian or nearest relative 
provided written consent. 
 
Randomisation and masking 
We randomly assigned whole practices to avoid contamination of intervention effects, because 
healthchecking some patients could influence practice with others. Practices were stratified by their 
size (number of GPs: 1–2, 3–4, or ≥5), and number of registered patients with intellectual disabilities 
(<20 or ≥20), in case these factors affected GPs’ skill level with this population. The investigation 
coordinator notified practices and the NHS intellectual disabilities primary care liaison team of group 
allocation so that they could provide training. 
 
Randomisation was undertaken and checked by staff of the Robertson Centre for Biostatistics who had 
no other association with the investigation or data management. Practices were randomised to 
intervention or control in batches; after baseline data had been obtained from a group of practices, 
they were allocated by identifying all possible sets of allocations that would maintain balance with 
respect to the stratification variables, and randomly selecting one of these sets. The computer 
programs and random seeds used to make these allocations were retained, and were stored with the 
randomisation codes in a separate network location from other study data, with restricted access. 
Initial statistical programming used dummy randomisation codes. Only after data collection was 
complete were true randomisation codes released to the statistician. 
 
Two research assistants were masked to allocation, and undertook the review of 9 month medical 
records and interviews with participants or carers. Practices notified participants or carers whether they 
would be offered a health check (so they were not masked). Nurses were instructed not to note in 
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patients’ records that a health check had been done. Consensus meetings research teams were 
masked to proceedings throughout. 
 
Procedures 
Health checks were delivered by practice nurses at recruited practices, after a training session. The 
training included communication techniques (including the recognition of pain); identification of 
common health presentations in this population, the role of carers, and common causes and severity of 
intellectual disabilities; and hints and tips to maximise the best use of appointment time. Written 
resources were also provided. 
 
The practices sent appointments, and provided health questionnaires for carers to complete in advance 
of the health check. The nurses used a health-checking instrument, which is designed for the needs of 
people with intellectual disabilities, to direct the health check and inform clinical decision making with 
respect to further standard investigations and treatments. The intervention initiated nurse contact to 
identify unmet needs. First, people with a carer who could think about, discuss, and record information 
in advance worked through a carer health check (for people who could not meet this criterion, this 
information was obtained verbally with the nurse at the health-check appointment). The carer’s health 
check was followed by the health check with the nurse. For health-check details see 
http://www.gla.ac.uk/researchinstitutes/healthwellbeing/research/mentalhealth/research/projects/heal
thchecksforadultswithintellectualdisabiltiesthehechidstudy/ 
 
Carer work, followed by a meeting with the nurse, reduces the nurse appointment length. Development 
of the health-check method was led by the Primary and Community Care Directorate of the Scottish 
Government. It aims to identify (1) health associations specific to syndromal causes of intellectual 
disabilities if present, and health needs that are more relevant to the intellectual disabilities population; 
(2) general health needs (specific symptoms, brief examination, etc); (3) health monitoring needs (ie, 
chronic diseases that need monitoring or actions), as identified for the GP Quality and Outcomes 
Framework (QOF), which contains a series of items that GPs should complete within specified 
timeframes for each of their patients with specified long-term disorders (eg, checking management of 
diabetes). Performance on the QOF (mostly the portion of completed items) defines the level of 
renumeration that practices receive for this component of their contract with the UK Government; and 
(4) health promotion needs (eg, access to population-wide screening programmes, weight 
management, and education about nutrition). 
 
Outcomes 
The primary outcome was the incidence of new health needs detected and met during the 9 months 
after randomisation. 
 
Secondary outcomes during the 9 months after randomisation were the extent of health monitoring 
(QOF items) and health promotion needs being met, the change in participant or carer-rated general 
health (by use of European Quality of Life-5 Dimensions [EQ- 5D] health-utility scores and Short Form 
[36] Health Survey [SF-36] scores), serious adverse events, and changes in resource use or costs. No 
changes were made to outcomes during study implementation.  
 
At baseline and 9 months after randomisation, we extracted data from primary care records about 
health needs, health-monitoring needs, and health-promotion needs addressed in primary care (eg, 
influenza immunisation), using a previously developed extraction method. We undertook interviews 
with participants or carers to complete the client-service receipt inventory,24 adverse events 
information, EQ-5D, SF-36, and health-promotion information not available in GP records, eg, dental 
appointments. At baseline, ability was assessed with the Vineland Scale.25 Two clinician investigators 
(S-AC and JM) had joint consensus conference meetings to establish whether health needs had been 
met at baseline and 9 months after randomisation; group allocation was concealed from both these 
investigators. 
 
Statistical analysis 
For 90% power and 5% significance, the previous Scottish intervention study18 showed that 51 
participants would be needed in each group to detect a rise in the proportion of new health needs 
being met, from a third to two-thirds (nQuery Advisor v 4.0, based on a continuity-corrected χ2 test); 
or 64 in each study group allowing for 20% attrition. The amount of inflation in sample size needed 
because of the cluster-randomised design depends on the average cluster size (expected to be 2.5 in 
this investigation) and intraclass correlation coefficient (ICC). We had no information from which to 
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estimate the ICC, but by assuming a value of 0.05, the increase in sample size needed would be less 
than 10%. Furthermore, the previous study18 used a more detailed health-check instrument, and since 
then accessibility of primary care might have improved. We therefore cautiously aimed to recruit 75 
participants per group. 
 
To determine whether participants were representative of the wider population with intellectual 
disabilities living in the same geographical area, we compared their characteristics for age, sex, and 
type of accommodation, by use of information from the primary-care learning-disabilities register for 
the health-board area. 
 
We adjusted all analyses for sex, age band (18–44, 45–64, or >65 years), level of intellectual ability, 
type of accommodation, and stratification factors. Analyses established any outcome measure 
differences at 9 months. We included participants in analyses on an intention-to-treat basis. Analyses 
used generalised linear mixed models, which took into account the cluster design, to estimate the 
between-group differences, adjusting for the noted covariates. Models used either a binomial or normal 
distribution, depending on the data. All models were extended to account for, and test for, an 
intervention-effect interaction with each severity of intellectual disabilities, and accommodation type. 
The number of serious adverse events was recorded. No interim analyses or unplanned analyses were 
undertaken. All analyses were done with SAS version 9.2, and a 5% significance level was used 
throughout; all tests were two-sided. 
 
Cost-effectiveness was estimated in terms of incremental cost per quality-adjusted life-year (QALY) 
gained over 9 months from an NHS perspective, including primary care, drugs, and emergency visits or 
calls. Unit costs were taken from the Personal Social Services Research Unit (2011), the British 
National Formulary, and NHS reference costs. The intervention cost was the nurse’s time (mean 48 
min, range 18–65); we were conservative in costing this for 1 h. No screening costs, or home visit 
checks were costed because these were assumed to be individual occurrences, with the standard being 
a health check by a nurse in the GP surgery (the standard rate per week for the practice nurse, as 
taken from standard reference costs, does allow for a portion of their time allocated to home visits). A 
within-trial measure of QALYs was identified from EQ-5D scores measured at baseline, 3, 6, and 9 
months, using the area-under-the-curve method.26 The effect of the intervention is the difference in 
mean change in QALYs in the alternative groups, taking into account the baseline level of utility. 
Resource use focused on the health check, and subsequent changes in health-care use including drug 
use and health-care consultations. We investigated the uncertainty surrounding estimates of cost and 
effects through bootstrapping by use of a two-stage non-parametric bootstrap27 to allow for clustering 
and correlation of costs and effects, because randomisation was at the GP rather than individual level. 
(Bootstrapping is a statistical method used to assess the uncertainty in an estimate, which involves 
resampling and replacement from the original data.) The results are presented graphically on the 
incremental cost-effectiveness plane; uncertainty about the cost-effectiveness of the intervention is 
summarised with a cost-effectiveness acceptability curve. The two-stage nonparametric bootstrap27 
was done with the STATA program version 12. All other analysis and modelling used the MS Excel 
program. Discounting was not applied because calculations related to a period of less than 1 year. This 
trial is registered with Current Controlled Trials, number ISRCTN43324841. 
 
Role of the funding source 
The funder of the study had no role in study design, data collection or analysis, data interpretation, or 
preparation of the manuscript. S-AC had full access to all study data and had final responsibility for the 
decision to submit for publication. 
 
 
Results 
Recruited practices were large, medium, and small in size, and had a range of registered patients with 
intellectual disabilities, so were representative for the area. 38 practices were randomly assigned to 
either standard care only (control group, n=67 patients) or standard care plus practice nurse-delivered 
health checks (intervention group, n=85 patients); five practices recruited no patients to the trial. 65 
(76%) of 85 participants in the intervention group received the intervention (figure 1). 66 (99%) of 67 
patients in the control group and 83 (98%) of 85 patients in the intervention group completed the 9 
month outcome assessment. Attempts to mask the research assistants during the trial were 
compromised because some participants revealed their group allocation.  
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Table 1 shows participants’ baseline characteristics. These did not differ from the wider population with 
intellectual disabilities living in the same area (median age 44 years [IQR 34–54], sex distribution of 
55% men to 45% women, 38% living with a family carer, and 45% living with a paid carer. Appendix 1 
shows health status and number of GP appointments for the preceding 9 months; as expected, the two 
groups seem balanced. 
 
Only 65 (76.5%) of the health-check group received the intervention (appendix 2). One person in the 
control group received a health check; he was the only enrolled participant at that particular GP 
practice. Delivery of the health check to this patient was the practice nurse’s own initiative; she did not 
receive health-check materials or training from the investigators. 
 
Table 2 shows health outcomes 9 months after randomisation. All except three participants completed 
the 9 month data collection. Tables 3 and 4 display the types of detected health needs, and the 
percentage of these needs that were met. More new health needs were met in the intervention group 
than in the control group, but this difference was not significant. The health-monitoring needs of long-
term disorders were significantly better met in the intervention group than in the control group (table 
5). Few health-promotion needs in the 9 months after randomisation were addressed in either group 
(table 6). 
 
General health improved in the intervention group compared with the control group according to EQ-
5D health-utility scores (0.15 vs 0.00, treatment effect 0.11 [95% CI 0.02–0.19] p=0.015) between 
baseline and 9 months after randomisation, but not for SF-36 scores (0.06 vs 0.02, treatment effect 
0.02 [–0.03 to 0.07] p=0.354). No serious adverse events attributable to the intervention were 
recorded.  
 
The within-trial economic analysis showed that the intervention was both more effective (0.0298 
versus -0.0029), with respect to the mean change in QALYs in the alternate groups (incremental 
difference 0.0327 [95% CIs –0.05 to 0.11]), and cheaper (incremental difference of £51 [–434 to 
362]) than standard care from an NHS perspective (appendix). The cost of the intervention was the 
nurse’s time to undertake the health check, which we costed at £51 per h.28 Figure 2 shows the 
uncertainty surrounding the incremental cost and incremental effect associated with the intervention. 
There is much uncertainty surrounding the existence and extent of the cost difference, and whether 
health checks are more effective and the extent of the effect difference, although on average health 
checks were cheaper and more effective. The cost-effectiveness acceptability curve (figure 3) shows 
the probability that the health-check intervention is cost effective for any cost-effectiveness threshold. 
The probability that health checks are cost effective is between 0.6 and 0.8, irrespective of the cost-
effectiveness threshold level. We also undertook a threshold analysis to explore the maximum value 
that the intervention could cost so that nurse checks remained dominant compared with standard care. 
The results of this analysis showed that the intervention cost could rise to from £51 to £95 per person 
before the intervention no longer dominated standard care. Moreover, we were conservative in costing 
1 h of a nurse’s time to deliver the health check when the average time was 48 min. 
 
We did not note any significant interaction of ability level, nor accommodation type, for the group 
difference in proportions of health needs met, health-monitoring needs met, or health-promotion needs 
met. The one exception was that the benefit of the intervention compared with the control group—with 
respect to health-monitoring needs being met—was greater for people who lived independent of carers 
(p=0.038). However, the study was not powered to detect intervention-effect heterogeneity between 
subgroups. 
 
 
Discussion 
Practice nurse-delivered health-check interventions for adults with intellectual disabilities were 
associated with significantly more health monitoring needs being met and generally higher health 
ratings than standard care for this population. Additionally, more newly detected health needs were 
met in the intervention group than in the control group, but the difference was not significant. The 
number of health-promotion needs being met did not differ between groups, which was low in both 
groups. The economic evaluation showed health checks to be both more effective and cost-saving 
during the trial period than standard care. As such, the use of health checks in this population 
dominated usual care. 
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Findings are both similar to and different from the Australian GP-delivered health-check trials.20,22 
These noted a non-significant trend towards new disease detection after 1 year, but they did not report 
the extent to which needs had been met or obtain data about health monitoring needs. Unlike our trial, 
they showed an increase in health-promotion activity, especially with testing of vision and hearing, 
giving tetanus boosters, and checking hepatitis B serology; in our trial the nurses enquired about vision 
difficulties and testing, then directed people towards an optometrist, rather than directly testing vision, 
and the health check did not include hepatitis B serology, so data are not similar. 
 
The intervention was less effective than the previous Scottish intervention study,18 in which health 
checks were undertaken by intellectual disabilities nurses rather than practice nurses, and took about 
five times longer. The follow-up duration was also longer in that study (1 year) compared with our 
study (9 months). The methods for the Scottish intervention study18 had limitations, however, because 
it was not randomised. 
 
Similar to two previous intervention cost reports, the health-check intervention in our study was 
inexpensive, with the cost of the intervention mainly offset by savings in drug costs (appendix). The 
intervention cost was the nurse’s time (mean 48 min); we were conservative in costing this at 1 h. The 
£100 paid to participating practices was not included in costing the intervention as we were estimating 
the cost-effectiveness of the approach if introduced in the NHS rather than in a trial setting. This 
payment covered the administrative time to accommodate the research assistants accessing 
information from participant records for the trial. We are unable to disentangle the effect that this 
payment could have had on participation; however, we suspect that this would only affect the choice to 
participate rather than the effectiveness of the intervention once individuals had participated and, as 
such, it would not necessarily affect the cost-effectiveness but rather scale of uptake if initiated. 
 
Improved health care (ie, better addressing of health-monitoring needs) is an important finding. QOF 
items are evidence-based, and provide pathways to clinically significant benefits for adults with 
intellectual disabilities who have health disorders. Significantly more health monitoring needs were 
addressed in the intervention group than in the control group, including management of long-term 
chronic conditions such as hypertension and diabetes, and it is well established that such management 
improves health. This finding is especially important in view of the barriers that adults with intellectual 
disabilities experience when trying to access primary care.4 This finding replicates results reported in 
the Scottish intervention study.18 Detection and addressing of unmet needs is also important because 
early detection could lead to better outcomes; our study might have been underpowered for this 
outcome, having used the same power as the previous Scottish intervention study.18 A better outcome 
in the intervention group was noted for the EQ-5D. Longer-term follow-up is necessary to investigate 
further the differences in health outcomes between the two groups. 
 
Practice nurses are very familiar with QOF items. Other highly prevalent, but often overlooked, 
disorders for adults with intellectual disabilities were only infrequently detected in our study. These 
disorders might already have been identified and addressed, or might not have been present in our 
study participants. Another interpretation is that the practice nurses, unfamiliar with the presentation 
and importance of these disorders in this population, and despite prompts by the health-check 
instrument, did not identify them. Two previous studies drew similar conclusions.29,30 A study of health-
check findings in 27 English practices showed processes incentivised through the QOF were completed 
in more health-checked individuals than those receiving standard care, but processes more specific to 
intellectual disabilities were poorly recorded for all.29 An assessment of the English health-check 
programme in 171 practices also reported this result.30 Educational approaches might therefore be of 
benefit, and joint learning by intellectual disabilities nurses and practice nurses could offer an 
innovative model. 
 
The study was powered from the Scottish intervention study.18 During the study, it soon became 
apparent that the mean number of participants recruited per practice would be greater than the 2.5 
originally assumed. However, initial (masked) assessment of outcomes suggested that the level of 
clustering of outcomes was very small (<0.1), suggesting that clustering of outcomes would not affect 
sample size. However, with respect to the primary outcome, the proportion reported in the control 
group (73%) was much higher than assumed in the sample size calculation (33%), so with the sample 
size achieved, we would have needed the primary outcome rate to be 92% in the intervention group 
(we noted 76%) to have had at least 80% power in detecting a difference. 
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The reasons for people not receiving a health check in the interventions group underline the pressures 
in primary care that result in inflexibility. Therefore, the 76% in the intervention group that received 
the health check is actually quite encouraging. In an NHS service (rather than this study, for which the 
intervention was one health check undertaken by a practice nurse), individuals who do not attend 
appointments could be followed up by a community intellectual disabilities team visit to find out why 
not, establish if any reasonable adjustments are needed, and help to facilitate the appointment. 
Community teams have a recognised role in supporting access to primary care, and such actions could 
be refocused. Because paid carers in the UK have a duty to address health care, if paid carers state 
that they are too busy to attend such health checks (as two in this study did), this could be drawn to 
the attention of service-provider managers for resolution, because it could be construed as breach of 
contract. The standard rate per h for the practice nurse, as taken from standard reference costs, does 
allow for a portion of their time allocated to home visits, though none were undertaken in this trial. 
 
The participants’ age range did not differ from that of the adult intellectual disabilities population; as 
expected, men outnumbered women (because more boys are born with intellectual disabilities than 
girls) and a range of accommodation types were reported. Participant characteristics were similar to 
the population with intellectual disabilities living in the same geographical area. The Greater Glasgow 
and Clyde area of Scotland in which this trial took place includes a mix of urban and semirural areas, 
and large and small practices that have between 0 and 80 registered patients with intellectual 
disabilities. We restricted the number recruited from each practice to include more practices and to 
capture a range of attitudes and skills in primary care, and the  balance achieved does not differ from 
characteristics of practices in the area. These study findings are therefore generalisable within the UK 
NHS, but perhaps not in countries where primary health-care systems are differently organised and 
delivered.  
 
Our study has several limitations. In retrospect, it was probably underpowered to detect a difference 
for the primary outcome measure because of the higher-than-expected proportion of health needs 
noted in the control group, compared with the previous Scottish intervention study which was similarly 
powered. The EQ-5D and SF-36 might not measure the health dimensions that adults with intellectual 
disabilities regard as most important. There could be inconsistency in whether people rate intellectual 
disabilities as a health problem. Some ratings were necessarily by proxy, and might not show the 
views of the adult with intellectual disabilities, and, because of staff turnover, baseline and follow-up 
measures were not always completed with the same carer. Research into the use of these instruments 
with this population is scarce,31 and we are not aware of other studies using them to measure changes 
in health status over time. Additionally, the economic evaluation excluded hospital costs with the 
exception of Accident and Emergency department costs. The intervention was delivered in primary care 
and these services were the most frequently accessed by both groups in a 12 month period in a 
previous economic investigation into the costs of a health check for people with intellectual 
disabilities.19 The results of that investigation also suggested that expanding the cost perspective 
beyond the NHS might strengthen cost-effectiveness because of savings in non-medical and social 
services, although these findings were not significant. No adverse events related to the intervention 
were reported in our trial but only 152 participants were included, so adverse events might occur in a 
larger population. 
 
Research in this discipline is scarce; however, investments have still been made in GP-delivered health 
checks for adults with intellectual disabilities in some countries (such as England and Wales), although 
not in others (eg, Scotland). This practice nurse-delivered health check was effective in some 
important domains, and cost effective. Its outcomes were either similar or favourable compared with 
the Australian GP-delivered health check.20 Are health checks performed better by practice nurses or 
intellectual disabilities nurses? Intellectual disabilities nurses have skills in the health-need profile, 
communication skills with adults with intellectual disabilities, and experience of working with carers. 
Practice nurses have skills in general health, and experience of working with GPs, and monitoring and 
managing disease. These skill sets are complementary, and perhaps suggest the benefits of joint 
working. Health checks delivered by practice nurses are indicated for this population, who typically 
would otherwise have poor access to primary care. 
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Research in context 
Systematic review 
People with intellectual disabilities experience substantial health inequalities compared with the general 
population. Clinical trials, current controlled trials, and an international clinical trials registry platform 
were searched. Additionally, we identified a systematic review that searched Medline, CINAHL, Web of 
Science, and PsycINFO.17 Results from the review showed very little previous evidence, with no 
previous controlled trials of practice nurse-delivered health checks for people with intellectual 
disabilities, and only two controlled trials identified of GP-delivered health checks in Australia (that 
showed some increase in health-promotion activities). 
 
Interpretation 
This is the first randomised controlled trial of practice nurse-delivered health checks for adults with 
intellectual disabilities. The intervention produced better general health ratings and health-care 
improvements, which might improve longer-term health compared with standard care, but not the 
number of new health needs met during 9 months; it was also cheaper and more effective. Health 
checks designed for people with intellectual disabilities are needed, rather than health checks designed 
for the general population without selection for risk factors or disease. 
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Figure 1: Flow diagram  
 
  
  Analysed N=66 individuals              Analysed N=83 individuals 
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Figure 2: Incremental cost-effectiveness plane for health check compared to 
usual care  
 
 
The ICER i.e. the mean cost-effectiveness estimate is denoted by the red dot. 
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Figure 3: Cost-effectiveness acceptability curve for health check compared to 
usual care  
 
 
X-axis: Cost-effectiveness willingness to pay to QALYs 
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Table 1: Baseline characteristics of participants 
   Control group 
(n=67) 
 
Health-check 
group (n=85) 
 
 
     
 Age (years) 46·2 (38·2–57·3) 47·2 (34·5–54·6)  
 Women 28 (42%) 32 (38%)  
 Disability    
Mild intellectual disabilities 12 (18%) 18 (21%)  
Moderate intellectual disabilities 15 (22%) 28 (33%)  
Severe intellectual disabilities 23 (34%) 26 (31%)  
Profound intellectual disabilities 17 (25%) 13 (15%)  
 Accommodation    
With a family carer 27 (41%) 34 (40%)  
With a paid carer 30 (45%) 36 (42%)  
Independent (no carer)   9 (14%) 15 (18%)  
  
Data are number (%) or median (IQR range) for the intention-to-treat population. 
 
 
  
 
 
 
      
 
  
16 
 
Table 2: Health outcomes during the 9 months after randomisation 
   Control group 
(n=66) 
 
Health-check 
group (n=83) 
 
Comparison for control vs health 
check 
 
    OR (95% CI)  p value  
 Health needs      
 Newly detected   2 (0–11)   1 (0–8)   1·73 (0·93–3·22)  0·085  
 Mean % met 72·6% (SD 35·4) 76·4% (SD 36·5)    
 Health-monitoring needs      
 Newly detected   2 (0–22)   2 (0–20)   2·38 (1·31–4·32) 0·0053  
 Mean % met 56·8% (SD 29·4) 69·9% (SD 34·2)    
 Health-promotion needs      
 Newly detected   6 (1–9)   6 (1–9)   0·98 (0·73–1·32) 0·878  
 Mean % met 35·9% (SD 23·1) 35·3% (SD 22·3)    
 Appointments and drugs      
 GP appointments   3 (0–17)   2 (0–16) –0·66 (–1·66 to 0·34)*    0·191  
 Medicines needed   7 (0–26)   5 (0–22)   0·41 (–0·70 to 1·51)* 0·467  
  Data are median (min–max). OR=odds ratio. GP=general practitioner. *Effect estimate (95% CI) reported is adjusted mean 
difference for the change in the number of GP appointments, or the change in the number of drugs needed, at 9 months 
from baseline. 
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Table 3: Types of health needs detected and treated during 9 months after 
randomisation  
 
     
  Control group (n=66) Health-check group (n=83)  
   Number of 
events 
detected 
 
Number of events 
treated/number of 
events detected (% 
of detected needs 
treated) 
 
Number of 
events 
detected 
 
Number of events 
treated/number of 
events detected (% 
of detected needs 
treated) 
 
 Infections    7   7/7 (100%)   3    3/3 (100%)  
 Neoplasm   0   0   0   0  
 Blood disorders   0   0   2   2/2 (100%)  
 Endocrine disorders   4   4/4 (100%)   1   1/1 (100%)  
 Mental disorders 14   7/14 (50%) 10   4/10 (40%)  
 Nervous system 24   7/24 (29%) 17   4/17 (24%)  
 Eye disorders   5    4/5 (80%)   2   2/2 (100%)  
 Ear disorders   6   6/6 (100%) 15 15/15 (100%)  
 Circulatory disorders   9   5/9 (56%) 14   7/14 (50%)  
 Respiratory disorders 14 14/14 (100%) 15 15/15 (100%)  
 Gastrointestinal disorders   6   5/6 (83%) 11 11/11 (100%)  
 Skin disorders 20 20/20 (100%) 24 23/24 (96%)  
 Musculoskeletal disorders   5   4/5 (80%) 15 14/15 (93%)  
 Genito-urinary disorders 17 15/17 (88%)   5   5/5 (100%)  
 Pregnancy   0   0   0   0  
 Perinatal disorders   0   0   0   0  
 Congenital disorders   0   0   0   0  
 Other disorders   6   3/6 (50%)   1   0/1 (0%)  
 Injury or poisoning   5   5/5 (100%)   2   1/2 (50%)  
 External causes   0   0   0   0  
       
 Data are number detected, and number treated/number detected (%). Health disorders classified by ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10). 
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Table 4: Most often reported health needs detected and treated during 9 
months after randomisation  
 
     
  Control group (n=66) Health-check group (n=83)  
   Number of events 
detected 
 
Number of events 
treated/number of 
events detected (% 
of detected needs 
treated) 
 
Number of events 
detected 
 
Number of events treated/number 
of events detected (% of detected 
needs treated) 
 
 Outstanding blood tests (excluding tests included in the QOF) 
23   8/23 (35%) 16    6/16 (38%)  
 Skin rash, psoriasis, or eczema 12 12/12 (100%) 20 18/20 (90%)  
 Chest infection 13 13/13 (100%) 12 12/12 (100%)  
 Urinary tract infection 13 12/13 (92%)   3   3/3 (100%)  
 Injury   6   5/6 (83%)   8   6/8 (75%)  
 Cellulitis or ulcers   9   9/9 (100%)   3   3/3 (100%)  
 Fungal infection   3   3/3 (100%)   7   7/7 (100%)  
 All other reported health needs 63 44/63 (70%) 68 52/68 (77%)  
       
 Data are number detected, and number treated/number detected (%). Data are for ten most often reported health disorders. QOF=GP Quality and Outcomes Framework 
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Table 5: Long-term disorders during 9 months after randomisation and 
relevant QOF items for each disorder 
     
  Control group (n=66) Health-check group (n=83)  
  Number of participants 
with each health need 
(%) 
Median number of QOF items 
that were treated/ median 
number of items that were 
applicable (median % of items 
that were treated) 
Number of participants 
with each health need 
(%) 
Median number of QOF items that 
were treated/median number of 
items that were applicable (median 
% of items that were treated) 
 
 Coronary heart disease   1 (1·5%) 3/9 (33·3%)   4 (4·8%)   5/6 (90%)  
 Heart failure   0 (0%) 0 (0%)   0 (0%)   0 (0%)  
 Stroke or TIA   1 (1·5%) 4/5 (80%)   1 (1·2%)   7/7 (100%)  
 Hypertension   7 (10·6%) 1/2 (50%) 16 (19·3%)   2/2 (100%)  
 Diabetes   7 (10·6%) 9/14 (64%)   8 (9·6%) 10·5/12 (85%)  
 COPD   1 (1·5%) 2/4 (50%)   0 (0%)   0 (0%)  
 Epilepsy 21 (31·8%) 2/3 (67%) 17 (20·5%)   1/3 (33%)  
 Hypothyroidism   6 (9·1%) 1/1 (100%) 10 (12·0%)   1/1 (100%)  
 Psychosis   6 (9·1%) 0·5/2 (25%)   4 (4·8%)   0/1·5 (0%)  
 Asthma   4 (6·1%) 0·5/1 (50%) 11 (13·3%)   0/1 (0%)  
 Atrial fibrillation   0 (0%) 0 (0%)   0 (0%)   0 (0%)  
 Chronic kidney disease   1 (1·5%) 2/3 (67%)   2 (2·4%)   3/3 (100%)  
 Smoking domain   9 (14·1%) 1/1 (100·0%) 27 (32·5%)   1/1 (100%)  
 Depression screening   6 (9·4%) 0/1 (0%) 11 (13·3%)   1/1 (100%)  
       
 Data are n (%) of participants with each health need; median number of QOF items that were treated/median number of QOF items that were applicable (median % of items that were treated). QOF=GP Quality and Outcomes Framework. TIA=transient ischaemic attack. COPD=chronic obstructive pulmonary disease. 
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Table 6: Health-promotion needs during the 9 months after post-
randomisation 
     
  Control group (n=66) Health-check group (n=83)  
  Number of events detected 
Number of events treated/ 
number of events detected   
(% of detected needs treated) 
Number of events 
detected 
Number of events treated/number 
of events detected (% of detected 
needs treated) 
 
 Smoking   4 2/4 (50%)   9   5/9 (56%)  
 Alcohol excess   0    0   0   0  
 Illicit drug use   0    0   1   1/1 (100%)  
 Obesity 39 10/39 (26%) 57 21/57 (37%)  
 Cervical screening 20   6/20 (20%) 27   5/27 (19%)  
 Mammography 11   4/11 (36%) 15   6/15 (40%)  
 Tetanus immunisation 62 13/62 (21%) 80 11/80 (14%)  
 Polio immunisation 62 11/62 (18%) 79 12/79 (15%)  
 Influenza immunisation 44 27/44 (61%) 48 34/48 (71%)  
 Hepatitis B vaccination 24 2/24 (8%) 27   3/27 (11%)  
 Dental check-up 63 43/63 (68%) 80 41/80 (51%)  
 Vision test   0    0   0   0  
 Hearing test   0    0   0   0  
 Sex and relationship information   0    0   0   0  
 Thyroid function tests (Down 
syndrome) 
  7   6/7 (86%) 14   8/14 (57%)  
 Being sedentary 63 20/63 (32%) 80 27/80 (34%)  
 Being underweight   0    0   2   1/2 (50%)  
 Other   1   0/1 (0%)   0   0  
       
 Data are number of health-promotion needs detected (%) and number of detected health promotion needs treated/ health-promotion needs detected.  
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Appendix 1: Health service usage and health status for the nine months prior 
to baseline  
 
 Control group 
N=67 
Health check group 
N=85 
Health needs 
Newly detected 
   Mean percentage met 
 
1 (0 -17) 
  74·7 
 
1 (0 – 17) 
  73·3 
Health monitoring needs  
Newly detected 
   Mean percentage met 
 
2 (0 – 23) 
  57·9 
 
2 (0 – 24) 
  61·8 
Health promotion needs  
Newly detected 
   Mean percentage met 
 
6 (3 – 8) 
  41·1 
 
6 (4 – 9) 
  36·4 
GP appointments 3 (0 – 16) 2 (0 – 27) 
Medication 6 (0 – 24) 4 (0 – 21) 
 
Summaries reported are either the median (minimum, maximum) or the mean  
percentage met.  
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Appendix 2: Delivery of intervention  
 
 Standard care group 
N=67 
Health check group 
N=85 
Health checks completed 1 (1·5) 65 (76·5) 
Reason for no health check 
  Control group 
  Sole practice nurse went on sick leave 
  Sent appointment but didn’t attend 
  Paid carers said they were too busy 
  No appointment sent 
  Too depressed to attend the practice 
  Appointment offered clashed with 
college course 
 
66 (98·5) 
 
 
8 (9·4) 
6 (7·1) 
2 (2·4) 
2 (2·4) 
1 (1·2) 
1 (1·2) 
 
Summaries reported are the number of participants (percentage)  
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